These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5066310)

  • 1. [The absorption, distribution and excretion of 14 C-L-DOPA in the mouse and uptake into the cat corpus striatum].
    Yoshikawa M; Sato Y
    Yakugaku Zasshi; 1972 May; 92(5):551-64. PubMed ID: 5066310
    [No Abstract]   [Full Text] [Related]  

  • 2. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK; Chase TN; Colburn RW; Kopin IJ
    Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs affecting monoamines in the basal ganglia.
    Bartholini G; Pletscher A
    Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). 3. Absorption, distribution and excretion of D- and L-DOPA-14C in rats following intravenous and oral administration.
    Shindo H; Nakajima E; Kawai K; Miyakoshi N; Tanaka K
    Chem Pharm Bull (Tokyo); 1973 Apr; 21(4):817-25. PubMed ID: 4727354
    [No Abstract]   [Full Text] [Related]  

  • 5. Axoplasmic transport of dopamine in nigro-striatal neurons.
    Fibiger HC; McGeer EG; Atmadja S
    J Neurochem; 1973 Aug; 21(2):373-85. PubMed ID: 4125072
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute effects of morphine on dopamine synthesis and release and tyrosine metabolism in the rat striatum.
    Gauchy C; Agid Y; Glowinski J; Cheramy A
    Eur J Pharmacol; 1973 Jun; 22(3):311-9. PubMed ID: 4354579
    [No Abstract]   [Full Text] [Related]  

  • 7. Transmitter-like basal and K(+)-evoked release of 3,4-dihydroxyphenylalanine from the striatum in conscious rats studied by microdialysis.
    Nakamura S; Goshima Y; Yue JL; Misu Y
    J Neurochem; 1992 Jan; 58(1):270-5. PubMed ID: 1345766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
    Morin N; Morissette M; Grégoire L; Gomez-Mancilla B; Gasparini F; Di Paolo T
    Neuropharmacology; 2013 Oct; 73():216-31. PubMed ID: 23756168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in whole tissue biosynthesis of gamma-amino butyric acid (GABA) in basal ganglia of the dystonia (dtAlb) mouse.
    Messer A; Gordon D
    Life Sci; 1979 Dec; 25(26):2217-21. PubMed ID: 542100
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo release of newly synthesized GABA in the basal ganglia of the cat.
    Gauchy C; Kemel ML; Glowinski J; Besson MJ
    Adv Biochem Psychopharmacol; 1981; 29():183-91. PubMed ID: 7257927
    [No Abstract]   [Full Text] [Related]  

  • 11. Decarboxylation of DL-2,4-dihydroxyphenylalanine (2,4-DOPA) to 2,4-dihydroxyphenylethylamine in mouse striatal slices.
    Orosz D; Cohen G
    Eur J Pharmacol; 1987 Apr; 136(3):441-4. PubMed ID: 3111867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gamma-hydroxybutyrate and gamma-butyrolactone on dopamine synthesis and uptake by rat striatum.
    Bustos G; Kuhar MJ; Roth RH
    Biochem Pharmacol; 1972 Oct; 21(19):2649-52. PubMed ID: 4661622
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution of DOPA-2- 14 C in relation to DOPA-1- 14 C (carboxyl- 14 C-labelled DOPA) in mice before and after inhibition of DOPA-decarboxylase, studied by whole-body autoradiography.
    Tjälve H; Ullberg S
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):376-88. PubMed ID: 4627124
    [No Abstract]   [Full Text] [Related]  

  • 14. Feedback control of dopamine synthesis in dopaminergic terminals of the rat striatum.
    Javoy F; Agid Y; Bouvet D; Glowinski J
    J Pharmacol Exp Ther; 1972 Sep; 182(3):454-63. PubMed ID: 4403433
    [No Abstract]   [Full Text] [Related]  

  • 15. The release in vivo of dopamine synthesized from labelled precursors in the caudate nucleus of the cat.
    Riddell D; Szerb JC
    J Neurochem; 1971 Jun; 18(6):989-1006. PubMed ID: 4398120
    [No Abstract]   [Full Text] [Related]  

  • 16. High levels of dopamine activity in the basal ganglia of cigarette smokers.
    Salokangas RK; Vilkman H; Ilonen T; Taiminen T; Bergman J; Haaparanta M; Solin O; Alanen A; Syvälahti E; Hietala J
    Am J Psychiatry; 2000 Apr; 157(4):632-4. PubMed ID: 10739427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced changes of striatal cholinergic and dopaminergic functions in rats with spreading depression.
    Keller HH; Bartholini G; Pletscher A
    J Pharm Pharmacol; 1973 Jun; 25(6):433-6. PubMed ID: 4146579
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain.
    Wurtman RJ
    Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). IV. Urinary and tissue metabolites of D- and L-DOPA-14C after intravenous and oral administration to rats.
    Shindo H; Komai T; Tanaka K; Nakajima E; Miyakoshi N
    Chem Pharm Bull (Tokyo); 1973 Apr; 21(4):826-36. PubMed ID: 4727355
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of chronically administered L-dopa in normal and lesioned cats.
    Langelier P; Roberge AG; Boucher R; Poirier LJ
    J Pharmacol Exp Ther; 1973 Oct; 187(1):15-26. PubMed ID: 4746324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.